{"title": "World Journal of Gastroenterology", "author": null, "url": null, "hostname": null, "description": null, "sitename": null, "date": "2023-01-01", "cleaned_text": "and Toll-like receptors in Children: Drugs 2018; 20(4): 315 doi: |2|| | Sok-Ja Janket, Martha E. Nunn, Erdjan Salih, Alison E. Baird. Translational Oral Health Research. 2018; Spalding. Non-alcoholic fatty liver disease: A sign of systemic disease. Metabolism 2017; 72: 94 doi: |5|| | Liver Disease: A Vicious Circle of Dysfunctions Orchestrated Gut Microbiome. Biology 2022; 11(11): |6|| Rawala, Aysha Aslam, role of probiotic and synbiotic therapy in aminotransferase levels and inflammatory markers in patients with nonalcoholic fatty liver disease - a systematic review and meta-analysis. European Journal of Gastroenterology & Hepatology 2019; 31(6): |7|| E. Mishina, P. O. Bogomolov, M. V. Matsievich, K. Yu. Kokina, A. Yu. Mayorov, Immunology (Russia) 2019; 21(5): 945 doi: |8|| | Kylynda C. Bauer, Paula Victoria Ayala, Anna Creus-Cuadros, B. Brett Finlay. Nonalcoholic Fatty Liver quercetin on high-fat diet-induced non-alcoholic fatty liver disease in mice is mediated by modulating intestinal microbiota imbalance and related gut-liver axis activation. Free Radical Biology and Medicine of the Microbiota and Toll-like Receptors in Obesity and Nonalcoholic Fatty Liver Disease. Journal of Obesity & Gut: The Disease. Prebiotic Activity and Reduces Adiposity and Nonalcoholic Fatty Liver Disease in Rats Fed a High-Fat Diet. The Journal of Nutrition 2021; 151(2): 352 doi: Aging: An Effect Related to the Modulation the SIBO in Non-Alcoholic Fatty Liver Disease: An Interplay between Liver, Gut Microbiota and Nutrition. Current Nutrition & Food Science Immune Response in Experimental Steatohepatitis Mouse Models. Digestive Diseases and Sciences 2017; 62(2): |16|| | Han, Hui-Ling Lin. Intestinal microbiota and type 2 diabetes: From mechanism insights to therapeutic perspective. World Journal of Gastroenterology 2014; 20(47): 17737-17745 doi: |17|| V. Suchkova, A. P. Lukashevich. Evaluation of the effectiveness of differentiated therapy of non-alcoholic fatty liver disease. Terapevticheskii arkhiv 2020; 92(2): 29 doi: |18|| | Joanna K. Hodges, Geoffrey Y. Sasaki, Richard S. Bruno. Anti-inflammatory activities of green tea catechins along the gut-liver axis in nonalcoholic fatty liver disease: lessons learned from preclinical and human studies. The Journal of Nutritional Biochemistry Carvalho Resistance Exercise Can Induce Inflammatory Pathways via Toll-Like 2 and 4: a Systematic Review. Sports Medicine - Open 2017; 3(1) doi: |20| |21|| | Dan Feng, Hongmin Zhang, Xin Jiang, Jun Zou, Qingrong Li, Haiyan Mai, Dongfang Su, Wenhua Ling, Xiang Feng. Bisphenol A exposure induces gut microbiota dysbiosis and consequent activation of gut-liver axis leading to \"Liver-gut\" axis: A target of traditional Chinese medicine for the treatment of non-alcoholic fatty liver disease. Frontiers in early liver inflammation in experimental NASH by modulating TLR4 trafficking in lipid rafts via NADPH oxidase activation. American Targeting of Hepatic Macrophages the Treatment of Liver Diseases. Frontiers in and Diseases. Membranes 2021; 11(11): 844 Martinez, Hung-I Jiang Zhisheng, Andreas Zirlik. Nutraceutical approaches to non-alcoholic fatty liver disease (NAFLD): A position paper from the International Lipid Expert Panel (ILEP). Pharmacological Research the Leading Cause of Non-Alcoholic Steatohepatitis. International Journal of Molecular Nu\u00f1o-L\u00e1mbarri. The role of the gut microbiota in the pathology and prevention of liver disease. The Journal of Nutritional Biochemistry 2018; 60: 1 doi: |29|| | Yujing Chu, Jing Liu, Lin Cui, Dekai Zhang. Toll-Like Receptors Recognize Intestinal Microbes in Liver Cirrhosis. Frontiers in Immunology 2021; 12 doi: |30|| Liang Tao, Jian-Wen Jiang, Shu-Sen Zheng. Application of metagenomics in the human Receptor 4 in the Development of Non-alcoholic Fatty Liver Disease. Avicenna Journal of Medical Biochemistry Cardiovascular involvement after liver transplantation: role of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis. Exploration of Medicine 2021; doi: |33|| | Brandon George Cholankeril, Donghee Kim, Aijaz The Therapeutic Implications of the Gut Microbiome and Probiotics in Patients with NAFLD. Diseases 2019; 7(1): 27 doi: |34|| | Mingnuan Han, Ting Zhang, Xingxin Ma, Bo Xiang, Xiayu Li. YAP at the progression of inflammation. Frontiers in Cell and Developmental Biology 2023; 11 doi: |37|| | Yuan Gao, Tian Tian. mTOR Signaling Pathway and Gut Microbiota in Various Disorders: Mechanisms and Potential Drugs in Pharmacotherapy. International Journal of Molecular Sciences 2023; 24(14): 11811 doi: |38|| | Kelli A. Lytle, Carmen P. Wong, Donald B. Jump, Anna Alisi. Docosahexaenoic acid blocks progression of western Zhao, Min Guo, Jun Feng, Zhennan Gu, Jianxin Zhao, Hao Zhang, Gang Wang, Wei Chen. Myristica fragrans Extract Regulates Gut Microbes and Metabolites to Attenuate Hepatic Inflammation and Lipid Metabolism Disorders via the AhR-FAS and NF-B Signaling Pathways in Mice with 1699 Wei, Chunchun Wei, Yongqiang Teng, Liang Li, Hehe Liu, Shengqiang Hu, Bo Kang, Hengyong Xu. Integrative analysis of transcriptome and lipidome reveals fructose pro-steatosis mechanism in goose fatty doi: Christine Bernsmeier. Non-Alcoholic Fatty Liver Disease - Changing the Prevalence of Liver Cancer?. Hepatology Moochhala. Gut microbiota intervention strategies using active components from medicinal herbs to evaluate clinical efficacy of type 2 diabetes - A review. Clinical and Translational Discovery 2023; 3(1) Xiaoxia Zhang, Lili Zhu, Zhen Wang, Haixia Lu, Ting Wang, Yiwei Li, Shaoqi Yang, Hao Wang. Inulin Exerts Beneficial Effects on Non-Alcoholic Fatty Liver Disease via Modulating gut Microbiome and Suppressing the Lipopolysaccharide-Toll-Like Receptor 4-M-Nuclear Factor-B-Nod-Like Receptor Protein 3 Pathway via gut-Liver Axis in Mice. Frontiers in Pharmacology 2020; 11 doi: |45|| | Hailong Li, Ziyang Xie, Yao Zhang, Yue Liu, Aijing Niu, Yingying Liu, Linbo Zhang, Lili Guan. Rosa rugosa polysaccharide attenuates alcoholic liver disease in Yan Li, Ru Ma, Qing Yao, Ji Wang, Zhiwei Sun, Yanbo Li, Caixia Guo. Silica nanoparticles aggravated the metabolic associated fatty liver disease through disturbed amino acid and proteomics for studying the effects of a biotechnologically produced oyster mushroom against hepatic steatosis Increased asprosin is associated with non-alcoholic fatty liver disease in children with obesity. World Journal of Pediatrics 2021; 17(4): 394 doi: |49|| | Jarren R. Oates, Melanie McKell, Maria E. Moreno-Fernandez, Michelle S. M. A. Damen, George S. Deepe, Joseph E. Qualls, Senad Divanovic. Macrophage Function in the Pathogenesis of Non-alcoholic Fatty Liver Disease: The Mac Attack. Frontiers in Immunology 2019; 10 doi: |50|| | Fan Xiong, Shangong Wu, Lu Qin, Mijuan Shi, Wenxiang Li, Hong Zou, Ming Li, Guitang Wang. Transcriptome analysis of grass carp provides insights into disease-related genes and novel regulation pattern of bile acid feedback in response to lithocholic acid. Aquaculture 2019; 500: 613 doi: |51|| | Daiyang Xia, Lin Yang, Yu Li, Jianying Chen, Xiufen Zhang, Heng Wang, Shuangshuang Zhai, Xianzhi Jiang, Giuseppe Meca, Shunxiang Wang, Liang Huang, Shanshan Zhu, Yang Fu, Zhu, Hui Ye, Wence Wang. inflammation involved intestinal 6571-6592 |53|| Ming-Qiang Wang, Zheng-Gen Wang, Hong-Hui Chen, Wen Chen, Qiong Yang, Ting-Na Lu, Qing Yang, Ji-Man He. Tanshinone IIA ameliorates non-alcoholic fatty liver disease through targeting peroxisome proliferator-activated receptor gamma and toll-like receptor 4. Journal of de Castro, Manoela Maciel dos Biomarkers in Biomarkers in and Applications 2015; : 1 |56|| Mengdi by Modulation of Intestinal Flora and the PI3K/AKT Signaling Pathway in C57BL/6 Mice. Journal of Agricultural and Food Chemistry 2023; 71(24): 9370 doi: transmembrane transcription factor CREBH: Potential role in non-alcoholic fatty liver disease (Review). Molecular Medicine Reports 2016; 13(2): 1455 |58|| Substrate structure-activity relationship reveals a limited lipopolysaccharide chemotype range for intestinal Fatty Liver Disease: The Central Role Porphyromonas gingivalis. 2021; Carreira dos Santos, Araki Ribeiro, Almeida da Odair Aguiar, Dan Linetzky Waitzberg, Claudia Cristina and synbiotic supplementation in experimental nonalcoholic fatty & Food Science 2019; 49(1): 75 doi: |63|| | Dan Feng, Jun Zou, Dongfang Su, Haiyan Mai, Shanshan Zhang, steatosis in ApoE/ mice by improving intestinal barrier function and reducing endotoxin and liver TLR4/NF-B inflammation. Nutrition & Zanlungo. Recent insights on the role of cholesterol in non-alcoholic fatty liver disease. Biochimica et Biophysica Acta (BBA) of |65|| SH Chu, Kaili Fu, Harry C H Lau, Yi-Xiang Wang, Anthony W H Chan, Hong Wei, Xiaoyong Yang, Joseph J Y Sung, Jun Yu. Dietary cholesterol drives fatty liver-associated liver cancer by modulating gut microbiota 2021; 70(4): 761 Ko, Yang. Crude extract of Camellia oleifera pomace ameliorates the progression of non-alcoholic fatty liver disease via decreasing fat accumulation, insulin resistance and inflammation. British Journal of Nutrition 2020; 123(5): 508 doi: |67|| | Jinliang Du, Rui Jia, Liping Cao, Zhengyan Gu, Qin He, Pao Xu, Guojun Yin, Yuzhong Ma. Regulatory effects of Glycyrrhiza total flavones on fatty liver injury induced by a high-fat diet in tilapia (Oreochromis niloticus) via Hiroshi Fukui. Gut molecular insight. Liver Research 2021; 5(2): 62 doi: |70|| | Meng-yang Qu, Yan-fang Pan, Min Xie, K.H.M. Mansur, Y. Fu. Research progress of intestinal microecology in the occurrence and development of precancerous lesions of liver. E3S Web of doi: |71|| Wilhelmsson. Expression of Jejunal Taste Receptors Morbid Shah. Therapeutic opportunities for alcoholic steatohepatitis and nonalcoholic steatohepatitis: exploiting similarities Lin, Xinrui Wu. Mendelian randomization analyses support causal relationship between gut microbiota and childhood obesity. Frontiers in Pediatrics 2023; 11 doi: |75|| | Gang Xu, Yu-Min Sui-Dan Zong-Rui Li, Zheng, Wu, Chunming Ding. Serum lipocalin-2 is a potential biomarker for the clinical diagnosis of nonalcoholic steatohepatitis. Clinical liver disease (NAFLD): Updates and future Liver Disease 2017; S T\u00f8lb\u00f8l, Sebastian T Thrane, Jens Christian Nielsen, Taylor S Cohen, David E Tabor, Fiona Fernandes, Andrey Tovchigrechko, Vrang, L Trevaskis, Henrik H Hansen. Towards a standard diet-induced and biopsy-confirmed mouse model of non-alcoholic steatohepatitis: Impact of dietary fat source. World Journal as a Target for Treatment of NAFLD/NASH. International Journal of Molecular pathophysiology of metabolic associated fatty liver disease: are macrophages a viable target therapy?. Hepatology J Parekh, Luis A Balart, David A Johnson. The Influence of the Gut Microbiome on Obesity, Metabolic Syndrome and Bj\u00f6rn Berglund, Lanjuan Li. An Update on the Efficacy and Functionality of Probiotics for the Treatment of Non-Alcoholic Fatty Liver Disease. Engineering 2021; 7(5): 679 doi: |83|| | Yong Jiang, Tao Han, ZhiGuang Zhang, Man Li, FengXiang Qi, Ying Zhang, YingLan Ji. Potential role of thymosin beta 4 in the treatment of nonalcoholic fatty liver disease. Chronic Diseases and Newton, Giovanni Cammarota. Gut Microbiota as a Driver of Inflammation in Nonalcoholic Fatty Liver Disease. Mediators of Inflammation | Noha Hassan, Somaia Azza R. El-Ansary, Muhammad Rania M. LPS/TLR4 Li, Weizhen Zhang. Gut Microbiota-Derived Components and Metabolites in the Progression of Non-Alcoholic Disease (NAFLD). 2019; 11(8): 1712 doi: |87|| Yi Ren, Jinpu Yang, Changzhou Cai, Weixin Cheng, Xinxin Zhou, Dan Lu, Feng Ji. Gut microbiome and microbial metabolites in NAFLD and after bariatric surgery: and causality. Frontiers in Microbiology 2022; 13 doi: |88|| | Craig James McClain, Laura Smart, Sarah Safadi, Irina Kirpich. Present Knowledge in to microbial-based therapies in type 2-diabetes. Infection, 104268 Cronstein, Radhika Muzumdar, Zhenwei Gong, Haim Werner, Shoshana Yakar. Growth Hepatic Lipid Metabolism. Diabetes 2016; 65(12): 3598 doi: |91|| | Wang Gu, Kang Wen, Chunchi Yan, Shuo Li, Tongjun Liu, Cheng Xu, Long Liu, Minmeng Zhao, Jun Zhang, Tuoyu Geng, Daoqing Gong. Maintaining intestinal structural integrity is a potential protective mechanism against inflammation in goose fatty liver. Poultry Science 2020; 99(11): 5297 Mei-Gui Lu, Chao-Mei Fu, Tian Xie. rhizoma and its major constituents against hepatobiliary disease: Liquan Huang. Gypenosides improves nonalcoholic fatty liver disease induced by high-fat diet induced through regulating LPS/TLR4 signaling pathway. : |95|| O. S. Oynotkinova, E. L. Nikonov, T. Y. Demidova, A. P. Baranov, E. V. Kryukov, E. I. Dedov, E. A. Karavashkina. Changes in the intestinal microbiota as a risk factor for dyslipidemia, atherosclerosis and the role of probiotics Adiposity Level, Metabolic Syndrome, and Insulin Resistance for the Risk of Nonalcoholic Fatty Liver Disease Diagnosis in Obese Children. Canadian and Manvendra K. Singh. Emerging roles of the Hippo signaling pathway in modulating immune response and inflammationdriven tissue repair and remodeling. The FEBS doi: Patarr\u00e3o, Joana I. Almeida, Carlos Penha-Gon\u00e7alves, M. Paula Macedo. How Inflammation Impinges on NAFLD: A Role for Yiming Baihua Zhou, Xinyin Li, Xinxin Zhang, Jiakun Dong, Xiumei Yang, Yang Wang, Yue Wu, Jianqing She, Jianjun Mu. The gut microbiota is associated with clinical response to statin treatment in patients with coronary artery disease. Atherosclerosis liver of the gut and the liver and metabolic modulation by some dietary factors and especially long-chain n-3 PUFA. Molecular Nutrition & Food Research 2016; | Wei Song, Tianyi Cui, torquensT3 alleviates via reconstruction of the gut microbiota and redox system. Journal of the Science of Food and Agriculture 2023; doi: |104|| | Cynthia Aparecida de Castro, Manoela Biomarkers in Biomarkers in and Applications 2017; : 129 doi: |105|| | Miaoqing Ye, Yinghui Tang, Jinyu He, Yueqing Cao, Shaojie Kou, Lin Wang, Lingli Sheng, Jingdong Xue. Alleviation of non-alcoholic fatty liver disease by Huazhi Fugan Granules is associated with suppression of TLR4/NF-B signaling pathway. Cl\u00ednica e Investigaci\u00f3n en 33(5): 257 doi: |106|| | Chunwei Cheng, Jun Tan, Wei Qian, Lei Zhang, Xiaohua Hou. Gut inflammation exacerbates hepatic injury in the high-fat diet induced NAFLD mouse: Attention to the gut-vascular barrier Ana Starcevic. The New Therapeutic Approaches in the Treatment of Non-Alcoholic Fatty Liver Disease. International Journal of Molecular Chiu, Myung-Gyu Choi, Sutep Gonlachanvit, Wei-Jei Lee, Wei Jie Jonathan Lee, Yeong Yeh Lee, Laurentius A Lesmana, You-Ming Li, Chun Kwok Wai Ng, Jose D Sollano, Simon Kin Hung Wong, Vincent W S Wong, Yunsheng Yang, Khek Yu Ho, Yock Young Dan. Asian consensus on the relationship between obesity and gastrointestinal and liver diseases. Journal of and alcohol-associated liver disease. American Journal Physiology-Gastrointestinal and Liver 325(1): G42 Microbiology doi: |111|| | Xiao-Jing Zhang, Peng Zhang, Hongliang Li. Interferon Regulatory Factor Signalings in Cardiometabolic Diseases. Liu. Phosphate Hepatotoxic Impacts on Zebrafish by Disrupting Hypothalamic-Pituitary-Thyroid the Intestinal Barrier, and Its Trojan Horse: Dysbiosis. Frontiers in Microbiology 2019; 10 doi: Javier Crespo, Javier Gonz\u00e1lez Gallego, Francisco Jorquera Plaza. An altered fecal microbiota profile in patients with non-alcoholic fatty liver disease (NAFLD) associated with Mao. network analysis in different nonalcoholic fatty liver e283 doi: |117|| Gaolong Shaofeng Wu, Jiaqiang Pan, Zhaoxin Tang, Lianmei Hu. Arsenic exposure induces intestinal barrier damage and consequent activation of gut-liver axis leading to inflammation and pyroptosis of liver in ducks. Science of The Total Environment 2021; 788: 147780 doi: |118|| Zhu, Jianbo Xiu, Yan Shen, Qi Xu. Hepatic progenitor cell activation is induced by the depletion of the gut microbiome in mice. Pathogenetic Wenhui Fan, Xin Zhang, Yuqian Zhang, Lanping Guo, Xiao Wang, Xinyan Qu, Hongjing Dong. Baicalein alleviates non-alcoholic fatty liver disease in mice by ameliorating intestinal barrier dysfunction. Food & Function 2023; 14(4): 2138 doi: |121|| | Dipti Deshpande, Hong Eckols, Uddalak Bharadwaj, David J. Tweardy, Laura Beretta. Multifunctional of a Small-Molecule STAT3 Inhibitor on NASH and Hepatocellular Carcinoma Cancer Research 2017; 23(18): 5537 doi: |122|| | Sebastian J. Wallace, Frank Tacke, Robert F. Schwabe, Neil C. Henderson. Understanding the cellular interactome of non-alcoholic liver Insights of OLFM2 and OLFM4 in Gut-Liver Axis and Their Potential Involvement in Nonalcoholic Fatty Liver Disease. International Journal of Molecular Sciences Santos. in the mechanistic link between the intestinal microbiome, renin-angiotensin system, and the development of obesity and metabolic syndrome. The Journal of mellitus. Life Sciences 2021; Rao, Taiyong Fang. The molecular basis of the associations between non-alcoholic fatty liver disease and colorectal cancer. Frontiers in Genetics 2022; 13 doi: |127|| | Laura J. Craven, Seema Nair Parvathy, Jeremy P. Burton, Michael S. Silverman. Response to Ianiro et al.. American Journal of Gastroenterology 2021; |128|| | fatty liver disease and non-alcoholic steatohepatitis in patients with HIV. The Lancet Gastroenterology & Samad. Involvement of TLR4/ CXCL9/ PREX-2 pathway in the development of hepatocellular carcinoma (HCC) and the promising role of early administration of lactobacillus plantarum in Wistar rats. Tissue and Cell 2019; 60: 38 |130|| | Wangxin Liu, Xianliang Luo, Jun Tang, Qiufen Mo, Hao Zhong, Hui Zhang, Fengqin Feng. A bridge for short-chain fatty acids to affect inflammatory bowel disease, type 1 diabetes, and non-alcoholic fatty liver disease positively: by changing gut barrier. European Journal of Nutrition 2021; 60(5): 2317 doi: |131|| | Cytokine modulation by etanercept ameliorates metabolic syndrome and its related complications induced in rats administered a high-fat high-fructose diet. Scientific Reports 2022; Masoud Arabfard. Identification Shared Gene Signatures in Different Stages of Nonalcoholic Fatty Liver Disease Using Integrated Lv, Yahui Pan Nie, Jun Lu, Yanlou Geng, Zhang Heng, Lihua Song. Alleviating the effect of quinoa and the underlying mechanism on hepatic steatosis in Cao, Shaojie Kou, Lin Wang, Lingli Sheng, Jingdong Xue. Alleviation of non-alcoholic fatty liver disease by Huazhi Fugan Granules is associated with suppression of TLR4/NF-B signaling e Investigaci\u00f3n en doi: Eom, Goo Hyun Kwon, Na Yeon Kim, Eun Ju Park, Sung Min Won, Hyeong Seop Kim, Sang Jun Yoon, Ji Ye Hyun, Min Kyo Jeong, Hee Jin Park, Byeong Hyun Min, Mi Ran Choi, Dong Joon Kim, Ki Tae Suk. Diet-Regulating Microbiota and Host Immune System in Liver Disease. International Journal of Molecular Sciences 2021; 22(12): 6326 doi: |136|| | of gut microbiota and metabolites in overweight and obesity of children. Frontiers in Endocrinology 2022; 13 doi: |137|| | Meiyu Jin, Lianwen Zheng, Yunfei Wei, Jiaqi Cheng, Di Zhang, Siru Yan, Haiyan Qin, Qi Wang, Xinxin Ci, Haihua Feng. Enterobacter cloacae aggravates metabolic disease by inducing inflammation and lipid Toxicology Pharmacology 2022; Sayed Majid Suhail Chunbao Li. inflammation exacerbates hepatic injury in C57BL/6J mice via gut-vascular barrier dysfunction with high-fat-incorporated meat oxidative stress and restore gut microbiota in |141|| Q. Song, X.P. Xiong, W.L. Yang, X. Gang, J.W. Hu, B. Hu, H.Y. Xu, L. Li, H.H. Liu, X.Y. Zeng, L. Chen, B. Kang, C.C. Han. Comparison of overfeeding effects on gut physiology and microbiota in two goose breeds. Poultry Science 2021; Obesity-Associated Liver Cancer through PGE2-Mediated Antitumor Cancer 2017; Zhang, Yui-Tung Wong, Ka-Yu Tang, Hiu-Yee Kwan, Tao Su. Chinese Medicinal Herbs Targeting the Gut-Liver Axis and Adipose Tissue-Liver Axis for Non-Alcoholic Fatty Liver Disease Treatments: The Ancient Wisdom and Modern Science. Frontiers in Endocrinology 2020; 11 Interactions Transplantation, Quercetin, and HighFat Diet Determine NonAlcoholic Fatty Liver Disease Development in GermFree Mice. Molecular Nutrition Food Research Adam Premature Infants With and Without Parenteral Nutrition-Associated Cholestasis. Journal of Pediatric MacPherson, Mi Zhou, Yanhua Gao, Pamela R. Wizzard, Paul W. Wales, Justine M. Turner, Benjamin P. Willing. Lipid Emulsion Formulation of Parenteral Nutrition Affects Intestinal Microbiota and Host Responses in Neonatal Piglets. Journal Enteral Yuan, Na Li, Qiang Huang, Lei He, Limei Wang, Zhiguo Liu. Perilla Oil Has Similar Protective Effects of Fish Oil on High-Fat Diet-Induced Nonalcoholic Fatty Liver Disease Promotes the Development of Steatohepatitis-related Hepatocellular Carcinoma in Mice. Journal of the in Nonalcoholic Fatty Liver Disease. Medical Sciences 2018; GPCRs get fatty: the role of G protein-coupled receptor signaling in the development and progression of nonalcoholic fatty liver disease. American Journal of Physiology-Gastrointestinal Marker of Metabolic Risk in Children. International Journal of Molecular Sciences the Chromosome 14q32.2 Maternally Imprinted Region Related to Progression of Non-Alcoholic Fatty Liver Disease in a Mouse Model. PLOS ONE 2016; e0154676 Xing, Yongsheng Liu, Yinsheng Xu. Changes silybinmediated treatment of highfat dietinduced |154|| of Microbiome-Targeted Therapy Nonalcoholic Disease. Overview of Cellular and Soluble Mediators in Systemic Inflammation Associated with Non-Alcoholic Fatty Liver Disease. International Journal of Molecular Sciences Gut Microbiota and Non-Alcoholic Fatty Liver Disease: Three Parts of the Same Axis. XiaoYu Niu, WeiHua Zou, MengQi Lu, Ling Dong, Fan Li, YanHong Chen, KeLi Yang, Hui Song. Interaction between gut microbiota dysbiosis and lung infection as gut-lung axis caused by |160|| | Y. Ilan. Review article: novel methods for the treatment of non-alcoholic steatohepatitis - targeting the gut immune system to decrease the systemic inflammatory response without immune suppression. Alimentary Qianqian Jiang, Keshu Xu. Resolvin D1 MAPK pathways and He, Zheng-Yan Gu, Galina Jeney, Pao Xu, Guo-Jun Yin. Effects of high-fat diet on antioxidative status, apoptosis and inflammation in Wei Zhu, Lin Wei, Wei Qu, Zhi-Gui Zeng, Yun-Sheng Yang. Characteristics of Gut Microbiota in Children With Biliary Atresia After Liver Transplantation. Frontiers in Physiology 2021; 12 |164|| | Geoffrey C. Farrell, Fahrettin Haczeyni, Shivakumar Chitturi. Obesity, Fatty Liver and Liver Cancer. Advances in Experimental Medicine and Biology 2018; 1061: 19 doi: |165|| | Rigaiqiqige Sa, Chi Feng, Hongxia Bai, Xiaoyu Yin, Lei Song, Xiaodong Hu, Rui Xu, Xinshan Li, Wu Dong, Jingfeng Yang, Jelena Zivkovic. Inhibitory Effects of Mongolian Medicine Yihe-Tang on Continuous Darkness Induced Liver Steatosis in Zebrafish. Evidence-Based Complementary and Alternative Medicine 2022; 2022: 1 doi: |166|| | Jiang Du, Yu Ji, Liang Qiao, Yanli Liu, Juntang Lin. Cellular endolysosomal dysfunction in the pathogenesis of nonalcoholic liver disease. Katharina Brandl, Bernd Schnabl. Is intestinal inflammation linking dysbiosis to gut barrier dysfunction during liver disease?. Expert Si-Qi Zhao, Wei-Jun Yang, Yong-Heng Feng, Chao Pan, Kun-Xing Yang, Yong Ma. Activation of Kupffer cells in NAFLD and NASH: mechanisms and therapeutic interventions. Frontiers in Cell and Developmental Biology 2023; 11 doi: |169|| | Safak Kiziltas. Toll-like receptors vitro investigation of food effects on human gut microbiota. Journal of Applied Biological Chemistry 2021; 64(1): 75 doi: |171|| | Hiroshi Fukui. Role of Gut Dysbiosis in Liver Diseases: What Have We Learned So Mediators of the Gut-Liver Axis in the Progression of Liver Diseases. Frontiers in Medicine 2021; 8 doi: |173|| | Ya. M. Vakhrushev, A. P. Lukashevich, E. V. Suchkova. ASSOCIATION OF INTESTINAL BACTERIAL OVERGROWTH AND DISEASES OF HEPATOBIARY TRACT. The Russian Archives of Internal Medicine 2019; 9(1): 64 doi: |174|| Wael A. Hassan, Karima El-Sayed. Vitamin D and Swimming Exercise Prevent Obesity in Rats under a High-Fat Diet via Targeting FATP4 and TLR4 in the Liver and Adipose Tissue. International Journal of Environmental Research and Public Health 19(21): 2 Diabetes, and Non-viral Hepatocarcinoma: 468 doi: |177|| | Minacapelli, Carolyn Catalano, Vinod K. Rustgi. of gut microbiota to microbial-based therapies. European Journal of Clinical Microbiology & Infectious Diseases 2020; 39(4): 613 doi: |180|| | Shuhua Yue Dong. Gypenosides counteract hepatic steatosis and intestinal barrier injury in rats with metabolic associated fatty liver disease by modulating the adenosine monophosphate activated protein kinase and Toll-like receptor 4/nuclear Hai Hu. Dysbiosis of gut microbiota after cholecystectomy is associated with nonalcoholic fatty liver Bingbing Li, Ying Hong, Juan Yan, Xin Tao, Gaosong Wu, Junli Ma, Weize Zhu, Lili Sheng, Liang Chen, Bo Li, Jing Zhong, Jun Du, Houkai Li. A botanical dietary supplement from white peony and licorice attenuates nonalcoholic fatty liver disease 2021; 91: Suchkova, A P Lukashevich. Non - alcoholic fatty liver disease Ho, Yi-Chun Tsai. Interrelationship of Gut Microbiota, Obesity, Body Composition and Insulin Resistance in Asians with Type 2 Diabetes Mellitus. Journal of Personalized Medicine 2022; 12(4): 617 doi: |185|| | Lu Wang, Bing Zhao, Ying Chen, Li Ma, Er-Zhen Chen, En-Qiang Mao. Biliary tract external drainage protects against intestinal barrier injury in hemorrhagic shock rats. World Journal B12 triggers liver macrovesicular steatosis and inflammation in rats with dextran sodium sulfate-induced Journal assessment in liver transplant for non-alcoholic steatohepatitis patients: What we do, what we should do. World Journal of Hepatology 2017; 9(15): 697-703 doi: |189|| | R. Wei, C. Han, D. Deng, F. Ye, X. Gan, H. Liu, L. Li, H. Xu, S. Wei. Research progress into the physiological changes in metabolic pathways in waterfowl 62(1): 118 doi: |190|| | Donald B. Depner, Sasmita Tripathy. Omega-3 Jos\u00e9 Carrilho, Claudia P is associated with insulin . Relationship between Gut Microbiota and Development and Prognosis of Autoimmune Liver Disease. Advances in Clinical Medicine 2022; Pimentel-Nunes. Review of the Relation Between Intestinal Microbiota and Toll-Like Receptors in the Metabolic Syndrome: What Do We Know So Far?. GE Portuguese Gastroenterology Mahato. MicroRNAs in the pathogenesis and treatment of progressive liver injury in NAFLD and liver fibrosis. Advanced Drug Delivery Reviews 2018; liver disease: hit multiple targets with a single shot. European Journal of Gastroenterology Fabris, Alastair J. Strain, Paolo Simioni, Erica Villa, Luca Fabris. The Neglected Role of Bile Duct Epithelial Cells in NASH. Seminars in Liver Disease 2022; 42(01): 034 doi: |199|| | Chen Yan, Cuili Zhang, Xuejiao Cao, Bin Feng, Xinli Li. Intestinal Population in Host with Metabolic Syndrome during Administration of Chitosan and Its Caroll J. Beltr\u00e1n. The immune response as a therapeutic target in non-alcoholic fatty liver disease. Frontiers in Immunology Javier Cubero. The Space of Disse: The Liver Hub in Health and Disease. Livers 2021; 1(1): 3 doi: |202|| | Junli Ma, Houkai Li. The Role of Gut Microbiota in Atherosclerosis and Hypertension. Frontiers Xu. Melatonin ameliorates imidacloprid-induced intestinal injury by negatively regulating the PGN/P38MAPK pathway in the common carp (Cyprinus Hepatic Steatosis in Nonalcoholic Fatty Liver Disease Rats by Regulating Inflammatory Factors Level via TLR4/NF-B Signaling Pathway. Frontiers in Pharmacology in non-alcoholic fatty liver disease. Free Radical Biology 2019; Kaiceng Wang, Yin Yuan, Jiafeng Xia, Bo Li, Lanjuan Li, Yongjun Sui. Longitudinal 16S rRNA Sequencing Reveals Relationships among Alterations of Gut Microbiota and Nonalcoholic Fatty Liver Disease Progression in |208|| | and non-alcoholic fatty liver disease: A critical and systematic review of clinical trials. Critical Reviews in Food Science and Nutrition 2019; 59(4): 693 doi: |209|| Xue Li, Yubei Wang, Ke Wu, Chuanguo Liu, Yuhong Liu, Wang. hepatoprotective effects deserticola Y.C. Ma: Integrated phytochemical analysis using UPLC-Q-TOF-MS/MS, target network analysis, and experimental assessment. Frontiers in Pharmacology 2022; 13 doi: |211|| | Jiashu Li, Zeyang Qu, Feng Liu, Hao Jing, Yu Pan, Siyu Guo, Chun Loong Ho. Principles in Microbiome Engineering. is related to the development and progression of hypercholesterolemia in non-alcoholic fatty liver Edward C. Oldfield, David A. Johnson. The Effects of Sleep on the Commensal Microbiota. Journal of insulin resistance in nonalcoholic steatohepatitis and liver disease development - a potential therapeutic target?. Expert Review of Gastroenterology & Liver Disease in HIV/HBV Patients - a Metabolic Imbalance Aggravated by Antiretroviral Therapy and Perpetuated by the Hepatokine/Adipokine Axis Breakdown. Frontiers in pathways of nonalcoholic fatty liver disease development and progression. Cellular and Molecular Life Sciences 2019; and obese children and adolescents. Frontiers in Endocrinology Fibrogenesis in MAFLD: Role of the Hepatic Immune System. Frontiers in Medicine 2021; 8 doi: |220|| | Kyoungsub Song, Hyunjoo Jinqiang Zhang, Wenbo Ma, Srikanta Dash, Chandrashekhar R. Gandhi, Tong Wu. YesAssociated Protein in Kupffer Cells Enhances the Production of Proinflammatory Cytokines and Promotes Cellular and Infection Microbiology 2023; 13 doi: |222|| | Alfredo Larrosa-Haro, Erika A. Caro-Sabido. Secondary Malnutrition and Nutritional Intervention in Cholestatic Liver Diseases in Infants. Frontiers in Nutrition 2021; 8 doi: |223|| | C.C. M. Abdulai, H.H. Liu, B. Kang, S.Q. Hu, L. Li, H.Y. Xu, J.W. Hu, S.H. Wei, C.C. Han. Effect of different types of sugar on gut physiology and microbiota in overfed goose. Poultry Science 2021; 100(7): 101208 of \"Gutbacteria-Gut-Liver Axis\" in Non-Alcoholic Fatty Liver Disease. Medical Link Between Choline Intake and Non-alcoholic Fatty Liver Disease. Journal of the American College of Nutrition 2019; 38(7): 633 doi: |226|| | Tacke. Dynamic plasticity of macrophage functions 175 doi: |227|| | Shu-Hua Shen, Cui Peng, Jie Fang, Bin Lv. Structural modulation of gut microbiota during alleviation of non-alcoholic fatty liver disease with Gynostemma pentaphyllum in rats. BMC and Nonalcoholic Fatty Liver Model of Gut-Liver Axis Interaction: From Pathophysiology to Potential Target of Treatment for Personalized Therapy. International Journal of Molecular Sciences 2021; 22(12): 6485 doi: |230|| | The role of gut microbiota in liver disease development and treatment. Liver Research 2019; 3(1): 3 doi: |231|| | Athina I. Amanatidou, George V. Dedoussis. Construction and analysis of protein-protein interaction network of non-alcoholic fatty liver disease. Computers in Biology and Medicine 2021; 131: 104243 doi: |232|| | Sahar Y. Al-Okbi, Amin, Amal E. A. Mohamed, Amr E. Edris, Osama M. Sharaf, Hoda B Mabrok, Asmaa A. Ramadan. Basil Essential Oil and Its Nanoemulsion Mitigate Non Alcoholic Steatohepatitis in Rat Model with Special Reference to Gut Microbiota. Journal of Oleo Science 2020; 69(8): Jing Xiong, Xia Chen, Zhijing Zhao, Ying Liao, Ting Zhou, Qian Xiang. A potential link between plasma shortchain fatty acids, TNF level and disease progression in nonalcoholic fatty liver disease: A retrospective study. Experimental in Patients with Chronic Inflammatory HDL-Targeted Pharmaceuticals 2022; 15(10): 1278 A Wilson. Phenylketonuria and Gut Microbiota: A Controlled Study S. Cohen. Can You Trust Your Gut? Implicating a Disrupted Intestinal Microbiome in the Progression of NAFLD/NASH. Frontiers in Circadian Rhythm, Obesity, Metabolic Syndrome, and Nonalcoholic Fatty Liver Pterostilbene and Its Parent Compound Resveratrol on Oxidative Stress and Inflammation in and Biology 2018; 1125: 85 doi: |242|| | Qiang Zheng, Hang Zhao, Dong Jia, Xu Han, Zhenning Liu, Min Zhao, Fumio Tsuji. Overexpression of TOLLIP Protects against Acute Kidney Injury after Paraquat Intoxication through Inhibiting NLRP3 Inflammasome Activation Modulated gut microbiome in a mouse model of Gulf War Illness causes neuroinflammation and intestinal injury via leaky gut and TLR4 Zhou, Chuang Xu. Intestinal Barrier Function-Non-alcoholic Fatty Liver Disease Interactions and Possible Role of Gut Microbiota. Journal of Agricultural and Food Chemistry 2019; 67(10): 2754 doi: |245|| | Wenwen Zhao, Meng Xiao, Jie Yang, Li Zhang, Yinying Ba, Rongrong Xu, Zongyang Liu, Haiyan Zou, Ping Yu, Xia Wu, Xiaoqing Chen. The combination of Ilexhainanoside D and ilexsaponin A1 reduces liver inflammation and improves intestinal barrier function in mice with high-fat diet-induced Yun Xie, LiMing Chen. Effect of celastrol on tolllike receptor 4mediated inflammatory response in free fatty acidinduced HepG2 cells. International of Microbiome Alterations Following the Enrichment of a High-Fat Diet With High Oleic Acid Peanuts Versus the Traditional Peanuts Cultivar in Mice. Frontiers in Nutrition 2022; 9 doi: |248|| | Sandra Mart\u00edn-Pel\u00e1ez, Montse Fito, Olga Castaner. Mediterranean Diet Effects on Type 2 Diabetes Prevention, Disease Progression, and Related Mechanisms. A Review. Nutrients Sullivan, Stephen Lasley, Ronnie Horner, Rita R. K Shetty, Nancy Klimas, Saurabh Chatterjee. Obesity Worsens Gulf War Illness Symptom Persistence Pathology by Linking Altered Gut Microbiome Species to Long-Term Gastrointestinal, Hepatic, and Neuronal Inflammation Mouse |250|| the pathogenesis of comorbid "}